Billionaire Mark Cuban's Discounted Pharmacy Has Launched: 'Bypass Middlemen and Outrageous Markups'
Billionaire Mark Cuban's Discounted Pharmacy Has Launched: 'Bypass Middlemen and Outrageous Markups' (msn.com)
Mark Cuban has opened up a new online pharmacy to help make generic drugs more affordable.
The Mark Cuban Cost Plus Drug Company (MCCPDC) officially launched last week, claiming to offer the "lowest prices on 100 lifesaving prescriptions, according to a press release.
The company is able to offer lower prices because it's a registered pharmaceutical wholesaler, meaning MCCPDC can "bypass middlemen and outrageous markups," per the press release.
"The pharmacy's prices reflect actual manufacturer prices plus a flat 15% margin and pharmacist fee," the press release states.
The company also "refuses to pay spread prices" to pharmacy benefits managers, which manage prescription drug benefits on behalf of health insurers, according to the Commonwealth Fund.
One of the medications available is Imatinib, a leukemia treatment that has a retail price of $9,657 a month and costs around $120 a month with a common voucher, per the press release. However, the MCCPDC offers a steep discount, making the drug available for $47 per month.
Two other notable prescriptions available at a significantly reduced price are Mesalamine, used for ulcerative colitis treatment, as well as gout treatment drug Colchicine.
Billionaire Mark Cuban's Discounted Pharmacy Has Launched: 'Bypass Middlemen and Outrageous Markups' (msn.com)
Mark Cuban has opened up a new online pharmacy to help make generic drugs more affordable.
The Mark Cuban Cost Plus Drug Company (MCCPDC) officially launched last week, claiming to offer the "lowest prices on 100 lifesaving prescriptions, according to a press release.
The company is able to offer lower prices because it's a registered pharmaceutical wholesaler, meaning MCCPDC can "bypass middlemen and outrageous markups," per the press release.
"The pharmacy's prices reflect actual manufacturer prices plus a flat 15% margin and pharmacist fee," the press release states.
The company also "refuses to pay spread prices" to pharmacy benefits managers, which manage prescription drug benefits on behalf of health insurers, according to the Commonwealth Fund.
One of the medications available is Imatinib, a leukemia treatment that has a retail price of $9,657 a month and costs around $120 a month with a common voucher, per the press release. However, the MCCPDC offers a steep discount, making the drug available for $47 per month.
Two other notable prescriptions available at a significantly reduced price are Mesalamine, used for ulcerative colitis treatment, as well as gout treatment drug Colchicine.